Lexston Life Sciences Corp
OTC:LEXTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lexston Life Sciences Corp
OTC:LEXTF
|
CA |
|
F
|
Fulgent Genetics Inc
F:7F0
|
US |
|
D
|
Danske Bank A/S
DUS:DSN
|
DK |
|
First Phosphate Corp
F:KD0
|
CA |
|
Western Star Resources Inc
F:4K2
|
CA |
|
Certive Solutions Inc
OTC:CTVEF
|
CA |
|
Electric Royalties Ltd
XTSX:ELEC
|
CA |
|
I
|
Ivision Tech SpA
F:O42
|
IT |
|
I
|
Imagine Lithium Inc
OTC:ARXRF
|
CA |
|
S
|
SportsHero Ltd
OTC:NIROF
|
AU |
|
I
|
Ispire Technology Inc
NASDAQ:ISPR
|
US |
Bankruptcy Probability
Lexston Life Sciences Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lexston Life Sciences Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
L
|
Lexston Life Sciences Corp
CNSX:LEXT
|
1.3m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
24.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
I
|
Intra-Cellular Therapies Inc
F:23I
|
13B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Blueprint Medicines Corp
F:2L9
|
7.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cidara Therapeutics Inc
F:20D0
|
5.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
A
|
Amicus Therapeutics Inc
F:AM6
|
3.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
MorphoSys AG
NASDAQ:MOR
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| SE |
|
BioArctic AB
STO:BIOA B
|
25.5B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
BGI Genomics Co Ltd
SZSE:300676
|
17B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sino Biological Inc
SZSE:301047
|
15.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| SE |
|
AddLife AB
STO:ALIF B
|
21.4B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lexston Life Sciences Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lexston Life Sciences Corp has total debt of 8k CAD. This includes both short-term (8k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.